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EDITORIAL
The need for uniformity in research definitions and the Standardized  
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Schuur Hospital and University of Cape Town
Medicine improves through the generation of hypotheses which are 
subsequently tested in clinical trials. These trials provide the foundations 
necessary for us to provide increasingly better care to our patients. 
Providing the best available medicine to our patients is summarised in the 
three principles of evidence-based medicine: i) appraisal of the totality 
of the medical evidence, ii) assessment of the quality of this evidence in 
order to make appropriate clinical management recommendations and 
iii) to understand and respect the patients’ preferences regarding the 
risk-benefit of any proposed intervention.1 
In order to understand the totality of the current evidence, a systematic 
review and meta-analysis of clinical trials (or observational cohorts, if no 
trials exist) is often required. However, despite comprehensive literature 
searches and the presence of numerous study or trial publications, it is 
sometimes either impossible to generate a meaningful meta-analysis, or 
only a poor meta-analysis is possible, which compromises the reader’s 
confidence in the findings. These scenarios are commonly due to 
inconsistent definitions of patient outcomes and differing time frames in 
reporting these outcomes. It is particularly distressing that something as 
simple as the outcome definitions adopted and the time at which these 
outcomes were reported can compromise a meta-analysis, especially 
when there are an adequate number of recruited patients in the meta-
analysis to provide sufficient power to answer the clinical question.
Two recent publications illustrate this point in high risk patients 
undergoing major noncardiac surgery. This is an area of practice with a high 
morbidity, where we would hope to accumulate evidence for beneficial 
practice earlier rather than later. The first example is cardiopulmonary 
exercise testing. In the United Kingdom, cardiopulmonary exercise 
testing is commonly conducted for preoperative risk stratification. 
Indeed, it was estimated that approximately 15 000 preoperative 
cardiopulmonary exercise tests were conducted in 2011 in England.2 
However, despite the volume of patients undergoing preoperative 
cardiopulmonary exercise testing, a recent systematic review which 
included 37 studies of 6 775 patients found it impossible to conduct a 
meta-analysis.3 Furthermore, despite this high-risk surgical cohort, not 
all the studies reported mortality, and when mortality was reported it 
was reported at various time intervals; in-hospital, 30 or 90 days, 1 or 
2 years, or worse still, not even reported. The definitions of morbidity were 
totally inconsistent. How is it that we have failed our patients so badly, 
that we cannot present data consistently in order to make meaningful 
clinical recommendations for a preoperative risk stratification tool, 
which is so commonly used for high risk noncardiac surgical patients?
The second example is the utility of haemodynamic goal-directed 
algorithms in decreasing patient morbidity following major noncardiac 
surgery. The largest trial to date, Optimisation of Cardiovascular 
Management to Improve Surgical Outcome (OPTIMISE) trial, was 
inconclusive.4 However, an updated meta-analysis that included this 
trial found haemodynamic goal-directed therapy algorithms to improve 
surgical outcomes, with a risk ratio for postoperative complications 
of 0.77, 95% confidence interval 0.71-0.83.4 Superficially, this result 
suggests that we should adopt haemodynamic goal-directed therapy 
algorithms in clinical practice. Unfortunately, the authors state that 
due to the inconsistent reporting of outcomes “with diverse criteria for 
complications reported over a variety of time frames,” our confidence in 
the result of the meta-analysis is compromised. Indeed, this is reflected 
in the heterogeneity of the point estimate (I2 of 31%),4 despite the large 
(and adequate) number of recruited patients in the trials. Surely this is 
an injustice.
In order to ensure that in the future we can aggregate data confidently, 
and hopefully achieve earlier consistent and reliable clinical signals 
from meta-analyses, an initiative known as the Standardized Endpoints 
for Perioperative Medicine (StEP) has been established and is led 
by Paul Myles and Mike Grocott.5 The principle of this initiative is to 
generate standardized outcome definitions for clinical trials. Adopting 
standardised outcome definitions would allow us to easily aggregate 
study or trial data to generate meaningful meta-analyses. Consistent 
outcome reporting would increase the number of studies or trials that 
could be included in a meta-analysis, which in turn would increase the 
event rate, and thus decrease the heterogeneity of the point estimates,6 
and therefore increase our confidence in the overall result or summary 
statistic of the meta-analysis. It is an injustice to patients who willingly 
participate in clinical studies or trials, if their data cannot contribute 
timeously to answering other clinically relevant questions, because the 
outcome definitions adopted by the investigators across studies or trials 
are inconsistent. The StEP initiative addresses this simple limitation in 
outcomes reporting. StEP will be launched at the 16th World Congress of 
Anaesthesiologists in Hong Kong later this year. It will be a session well 
worth attending.
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